SI-BONE (SIBN) Competitors $13.25 +0.20 (+1.53%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends SIBN vs. CNMD, TNDM, TMDX, SLNO, RXST, INMD, MDXG, ESTA, BLFS, and PLSEShould you be buying SI-BONE stock or one of its competitors? The main competitors of SI-BONE include CONMED (CNMD), Tandem Diabetes Care (TNDM), TransMedics Group (TMDX), Soleno Therapeutics (SLNO), RxSight (RXST), InMode (INMD), MiMedx Group (MDXG), Establishment Labs (ESTA), BioLife Solutions (BLFS), and Pulse Biosciences (PLSE). These companies are all part of the "medical equipment" industry. SI-BONE vs. CONMED Tandem Diabetes Care TransMedics Group Soleno Therapeutics RxSight InMode MiMedx Group Establishment Labs BioLife Solutions Pulse Biosciences CONMED (NYSE:CNMD) and SI-BONE (NASDAQ:SIBN) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, media sentiment, community ranking, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations. Which has better earnings and valuation, CNMD or SIBN? CONMED has higher revenue and earnings than SI-BONE. SI-BONE is trading at a lower price-to-earnings ratio than CONMED, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCONMED$1.29B1.65$64.46M$4.2116.30SI-BONE$157.04M3.54-$43.34M-$0.92-14.40 Do analysts prefer CNMD or SIBN? CONMED presently has a consensus price target of $79.80, indicating a potential upside of 16.28%. SI-BONE has a consensus price target of $23.00, indicating a potential upside of 73.58%. Given SI-BONE's stronger consensus rating and higher possible upside, analysts clearly believe SI-BONE is more favorable than CONMED.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CONMED 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80SI-BONE 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders and institutionals have more ownership in CNMD or SIBN? 98.1% of SI-BONE shares are owned by institutional investors. 6.8% of CONMED shares are owned by company insiders. Comparatively, 3.9% of SI-BONE shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Does the MarketBeat Community favor CNMD or SIBN? SI-BONE received 134 more outperform votes than CONMED when rated by MarketBeat users. Likewise, 68.29% of users gave SI-BONE an outperform vote while only 47.22% of users gave CONMED an outperform vote. CompanyUnderperformOutperformCONMEDOutperform Votes3447.22% Underperform Votes3852.78% SI-BONEOutperform Votes16868.29% Underperform Votes7831.71% Is CNMD or SIBN more profitable? CONMED has a net margin of 10.23% compared to SI-BONE's net margin of -23.82%. CONMED's return on equity of 13.84% beat SI-BONE's return on equity.Company Net Margins Return on Equity Return on Assets CONMED10.23% 13.84% 5.26% SI-BONE -23.82%-22.51%-16.53% Does the media favor CNMD or SIBN? In the previous week, SI-BONE had 1 more articles in the media than CONMED. MarketBeat recorded 2 mentions for SI-BONE and 1 mentions for CONMED. CONMED's average media sentiment score of 1.63 beat SI-BONE's score of 0.51 indicating that CONMED is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CONMED 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive SI-BONE 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk and volatility, CNMD or SIBN? CONMED has a beta of 1.46, indicating that its share price is 46% more volatile than the S&P 500. Comparatively, SI-BONE has a beta of 1.2, indicating that its share price is 20% more volatile than the S&P 500. SummaryCONMED beats SI-BONE on 10 of the 18 factors compared between the two stocks. Ad Brownstone ResearchMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.Click here to watch this demo and decide for yourself. Get SI-BONE News Delivered to You Automatically Sign up to receive the latest news and ratings for SIBN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SIBN vs. The Competition Export to ExcelMetricSI-BONESurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$547.29M$4.34B$5.12B$9.07BDividend YieldN/A41.46%4.91%4.22%P/E Ratio-14.4025.3791.3417.19Price / Sales3.5445.961,117.70116.80Price / CashN/A43.4542.6437.86Price / Book3.177.364.794.78Net Income-$43.34M$13.64M$120.07M$225.60M7 Day Performance-1.27%-2.80%-1.90%-1.23%1 Month Performance7.64%0.56%11.45%3.37%1 Year Performance-37.17%41.87%30.63%16.58% SI-BONE Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SIBNSI-BONE4.3095 of 5 stars$13.25+1.5%$23.00+73.6%-35.2%$547.29M$157.04M-14.40350Positive NewsCNMDCONMED4.6139 of 5 stars$71.74-1.1%$79.80+11.2%-36.7%$2.22B$1.29B17.234,000Positive NewsTNDMTandem Diabetes Care4.6384 of 5 stars$33.26+1.8%$53.81+61.8%+30.3%$2.18B$747.72M-16.922,400Positive NewsTMDXTransMedics Group4.0377 of 5 stars$63.95-0.5%$126.80+98.3%-20.1%$2.15B$241.62M68.36210Analyst ForecastSLNOSoleno Therapeutics4.477 of 5 stars$48.58+4.0%$74.83+54.0%+25.5%$2.09BN/A-14.0730RXSTRxSight2.9521 of 5 stars$38.75+3.9%$62.13+60.3%-11.8%$1.56B$89.08M-46.59220Analyst DowngradeGap DownINMDInMode3.6341 of 5 stars$18.18-0.4%$22.60+24.3%-21.7%$1.53B$423.75M9.87480Positive NewsMDXGMiMedx Group2.8123 of 5 stars$9.52+3.9%$12.00+26.1%+1.7%$1.40B$342.80M16.65895ESTAEstablishment Labs2.5211 of 5 stars$46.76+1.7%$60.60+29.6%+73.3%$1.31B$153.07M-17.83960Positive NewsBLFSBioLife Solutions1.2602 of 5 stars$27.44+2.8%$28.29+3.1%+79.4%$1.27B$146.96M-25.19409Analyst ForecastInsider TradeNews CoveragePLSEPulse Biosciences1.8256 of 5 stars$20.12+14.0%N/A+56.3%$1.24B$700,000.000.00140Insider TradeNews Coverage Related Companies and Tools Related Companies CONMED Competitors Tandem Diabetes Care Competitors TransMedics Group Competitors Soleno Therapeutics Competitors RxSight Competitors InMode Competitors MiMedx Group Competitors Establishment Labs Competitors BioLife Solutions Competitors Pulse Biosciences Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SIBN) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SI-BONE, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SI-BONE With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SIBN Stock Alerts